StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.56−0.04 (-7.07%)

Close on Nov 17, 2026Market cap $1.45MP/E –Yield –

Calidi Biotherapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Calidi Biotherapeutics's profit margin for the twelve months ending Dec 31, 2022 was -56504.4%. For fiscal 2022 it was -56504.4%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2022Dec 31, 2022-56504.4%–

More Calidi Biotherapeutics figures

See a number that looks wrong?